Clostridium difficile infection

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 8, Issue 5, 2008, Pages 544-547

  Clark, Tristan ^a   Wiselka, Martin ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Clostridium difficile; Diarrhoea; Epidemic strain; Nosocomial infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COLESTYRAMINE; FUSIDIC ACID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; METRONIDAZOLE; NITAZOXANIDE; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STEROID; TEICOPLANIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COLITIS; COLON RESECTION; DIARRHEA; DRUG EFFICACY; ENZYME IMMUNOASSAY; FECES CULTURE; HAND WASHING; HUMAN; INFECTION CONTROL; INFECTION RISK; INTESTINE PERFORATION; NONHUMAN; PRIMARY PREVENTION; RELAPSE; SECONDARY PREVENTION;

EID: 55049139927     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.8-5-544     Document Type: Article

References (20)

1. Aronsson B, Möllby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis 1985;151:476-81.
2. Warny M, Vaerman JP, Avesani V, Delmée M. Human antibody response to Clostridium difficile toxin A in relation to the clinical course of infection. Infect Immun 1994;62:384-9.
3. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silvia J Jr. Clostridium difficile-associated diarrhea and colitis. Review. Infect Control Hosp Epidemiol 1995;16:459-77.
4. Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 2007; 45:222-7.
5. Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366: 1079-84.
6. Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN. Proton pump inhibitors and hospitalization for Clostridium difficile- associated disease: a population-based study. Clin Infect Dis 2006;43:1272-6.
7. Turgeon DK, Novicki TS, Quick J et al. Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal specimens compared with the fibroblast cytotoxicity assay. J Clin Microbiol 2003;41:667-70.
8. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-7.
9. Apisarnthanarak A, Razavi B, Mundy LM. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis 2002;35:690-6.
10. Pepin J, Alary ME, Valiquette L et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591-7.
11. Moshkowitz M, Ben-Baruch E, Kline Z et al. Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Colorectal Dis 2007;9:173-7.
12. Pépin J, Routhier S, Gagnon S, Brazeau I. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 2006;42:758-64.
13. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769-75.
14. McFarland LV, Surawicz CM, Greenberg RN et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271:1913-8.
15. Juang P, Skledar SJ, Zgheib NK et al. Clinical outcomes of intravenous immune globulin in severe Clostridium difficile-associated diarrhea. Am J Infect Control 2007; 35:131-7.
16. Taylor NS, Bartlett JG. Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins. J Infect Dis 1980;141:92-7.
17. Bowden TA Jr, Mansberger AR Jr, Lykins LE. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 1981;47:178-83.
18. McNulty C, Logan M, Donald IP et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother 1997;40:707-11.
19. Hickson M, D'Souza AL, Muthu N et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007;335:80.
20. Muto CA, Blank MK, Marsh JW et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive 'bundle' approach. Clin Infect Dis 2007;45:1266-73.